C M Bidwell & Associates LTD Emergent Bio Solutions Inc. Transaction History

C M Bidwell & Associates LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$79.17 - $111.47 $189,612 - $266,970	-2,395 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$81.91 - $134.94 $43,412 - $71,518	530 Added 28.42%	2,395 $247,000
Q2 2020 Aug 14, 2020	BUY	$54.33 - $89.52 $101,325 - $166,954	1,865 New	1,865 $147,000

154

30.2M

137K

706K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $373M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.